Browsing by Author "Lazarevic, Tatjana (24168872300)"
Now showing 1 - 3 of 3
- Results Per Page
- Sort Options
- Some of the metrics are blocked by yourconsent settings
Publication Applying the molecular adsorbent recirculating system (MARS) in the treatment of acute liver failure (ALF) case report; [Primena mars (Eng molecular adsorbent recirculating system) u lečenju akutne insuficijencije jetre (AIJ) prikaz slučaja](2018) ;Gavrilovic, Jagoda (55257797600) ;Velickovic, Jelena Djordjevic (57203574772) ;Mijailovic, Zeljko (6506982098) ;Lazarevic, Tatjana (24168872300) ;Gavrilovic, Aleksandar (36163073800)Tomovic, Miroslav (21735448500)Acute liver failure (ALF) is a rare but life-threatening illness with multiple organ failure. The short-term mortality rate exceeded 80 % despite modern approaches in treatment. Drugs, infections by hepatic viruses and toxins are the most common causes of ALF. Progressive jaundice, coagulation disorder and hepatic encephalopathy are dominated as a clinical signs of the illness. We present a case of a 36-year-old Caucasian woman hospitalized in ICU due to yellow discoloration of the skin and sclera, severe disseminated coagulopathy and hemodynamic instability. ALF is developed due to Hepatitis B Virus infection, resulting in hepatic toxicity as well as coma. General condition rapidly improved after applying of Molecular Adsorbent Recirculating System (MARS), an extracorporeal liver support system based on albumin dialysis. It is relatively expensive treatment that is used for the patient with hepatic encephalopathy grade 3 or 4 in our institution. In conclusion, an early administration of MARS significantly reveals subjective and objective clinical improvement in the case we presented. © 2018, University of Kragujevac, Faculty of Science. All rights reserved. - Some of the metrics are blocked by yourconsent settings
Publication Erratum to: Vascular access registry of Serbia: a 4-year experience (International Urology and Nephrology, (2017), 49, 2, (319-324), 10.1007/s11255-016-1378-9)(2017) ;Jemcov, Tamara (14010471900) ;Dimkovic, Nada (6603958094) ;Jovanovic, Dragan (17734929100) ;Lazarevic, Tanja (58237174900) ;Mitic, Igor (6602508601) ;Naumovic, Radomir (55965061800) ;Simic-Ogrizovic, Sanja (55923197400) ;Velickovic, Radmila (24367610000) ;Andric, Branislav (26433154600) ;Antic, Miodrag (55190984100) ;Aracki, Snezana (57193213101) ;Arsenovic, Aleksandra (8559402600) ;Berto, Sabo Anika (57193206583) ;Bogdanovic, Jasmina (56585738900) ;Cekovic, Biljana (57193213606) ;Cuckovic, Cedomir (16941762300) ;Cukic, Zoran (55284202600) ;Cveticanin, Anica (6504820347) ;Djordjevic, Verica (57196659548) ;Dudic, Svetlana (57193215107) ;Gajic, Snezana (36124736300) ;Gojakovic, Biljana (55191339400) ;Golubovic, Predrag (57193211450) ;Gucic, Ljubinka (57193210034) ;Hadzibulic, Edvin (55191339000) ;Hadzifejzovic, Mersada (57193210721) ;Hamzagic, Nedim (57008300400) ;Haviza-Lilic, Branimir (6504026199) ;Ilic, Mira (59802166500) ;Ilic, Nasta (57193212749) ;Jelacic, Rosa (6507643100) ;Kostic, Mirjana (59805230400) ;Kovacevic, Miodrag (57193207055) ;Lazarevic, Tatjana (24168872300) ;Markovic, Rodoljub (8552493000) ;Micunovic, Vesna (56771469300) ;Milenkovic, Olgica (55946153300) ;Milenkovic, Radomir (57193214341) ;Milenkovic, Srboljub (55765257700) ;Milicevic, Biserka (57193211649) ;Milicevic, Olivera (55191339300) ;Nikolic, Zora (58254499500) ;Obrenovic, Slavica (57193206621) ;Orescanin, Mira (57193214885) ;Pavlovic, Stevan (57209066797) ;Pesic, Snezana (58074126100) ;Petkovic, Dobrila (57193212043) ;Pilipovic, Dragana (56771531100) ;Prokopovic, Miomir (23005876700) ;Radovanovic, Zoran (57193210261) ;Rakic, Nenad (57193208550) ;Rangelov, Vanja (6602282607) ;Sefer, Kornelija (56771458900) ;Sibalic, Simin Marija (57512203000) ;Stefanovic, Nikola (57193206504) ;Stojanovic, Dragoslav (57193209534) ;Stojanovic Stanojevic, Marina (16234709200) ;Tirmenstajn, Jankovic Biserka (57193206151) ;Vasic, Jovanovic Vesna (57193214911) ;Vasilic, Kokotovic Olivera (57193214237) ;Vojinovic, Goran (56771390200) ;Vuckovic, Dragana (57225433256) ;Vukelic, Vesna (57200869534) ;Vukic, Jasmina (57193206663) ;Zagorac, Nikola (57193214889)Zec, Nenad (55191215600)Authors want to correct the list of authors by expanding the number of coauthors and by including all contributors in the Vascular Access Study Group. Vascular Access Study Group (in alphabetic order): Andric Branislav, Antic Miodrag, Aracki Snezana, Arsenovic Aleksandra, Berto Sabo Anika, Bogdanovic Jasmina, Cekovic Biljana, Cuckovic Cedomir, Cukic Zoran, Cveticanin Anica, Djordjevic Verica, Dudic Svetlana, Gajic Snezana, Gojakovic Biljana, Golubovic Predrag, Gucic Ljubinka, Hadzibulic Edvin, Hadzifejzovic Mersada, Hamzagic Nedim, Haviza-Lilic Branimir, Ilic Mira, Ilic Nasta, Jelacic Rosa, Kostic Mirjana, Kovacevic Miodrag, Lazarevic Tatjana, Markovic Rodoljub, Micunovic Vesna, Milenkovic Olgica, Milenkovic Radomir, Milenkovic Srboljub, Milicevic Biserka, Milicevic Olivera, Nikolic Zora, Obrenovic Slavica, Orescanin Mira, Pavlovic Stevan, Pesic Snezana, Petkovic Dobrila, Pilipovic Dragana, Prokopovic Miomir, Radovanovic Zoran, Rakic Nenad, Rangelov Vanja, Sefer Kornelija, Sibalic Simin Marija, Stefanovic Nikola, Stojanovic Dragoslav, Stojanovic Stanojevic Marina, Tirmenstajn Jankovic Biserka, Vasic Jovanovic Vesna, Vasilic Kokotovic Olivera, Vojinovic Goran, Vuckovic Dragana, Vukelic Vesna, Vukic Jasmina, Zagorac Nikola, Zec Nenad. © 2017, Springer Science+Business Media Dordrecht. - Some of the metrics are blocked by yourconsent settings
Publication Galectin 3 (LGALS3) Gene Polymorphisms Are Associated with Biochemical Parameters and Primary Disease in Patients with End-Stage Renal Disease in Serbian Population(2022) ;Kovacevic, Zoran (7006680110) ;Lazarevic, Tatjana (24168872300) ;Maksimovic, Nela (36461365500) ;Grk, Milka (57208632180) ;Volarevic, Vladislav (57216641442) ;Jankovic, Marina Gazdic (56497061300) ;Djukic, Svetlana (55874004900) ;Janicijevic, Katarina (54414222700) ;Kovacevic, Marina Miletic (57191337133)Ljujic, Biljana (35746552900)Galectin 3 plays a significant role in the development of chronic renal failure, particularly end-stage renal disease (ESRD). The aim of our study was to investigate the association between Gal-3 and biochemical parameters and primary disease in ESRD patients, by exploring the polymorphisms LGALS3 rs4644, rs4652, and rs11125. A total of 108 ESRD patients and 38 healthy controls were enrolled in the study. Genotyping of LGALS3 gene rs4644, rs4652, and rs11125 polymorphisms was performed by polymerase chain reaction–restriction fragment length polymorphism (PCR–RFLP). By multivariate logistic regression analysis, we found that LGALS3 rs4644 CC and rs4652 AA genotypes were significantly associated with a higher risk for lower hemoglobin, higher level of parathyroid hormone, and also occurrence of diabetes mellitus and arterial hypertension. The CAA haplotype was significantly more common in patients with diabetes, low hemoglobin level, and normal PTH level. It has been observed as well that the ACT haplotype was more common in patients with low glomerular filtration, low PTH, and normal hemoglobin level. We found that the LGALS3 rs4644 and rs4652 gene polymorphism may be involved in the pathogenesis and appearance of complications in ESRD patients and thus could be considered a new genetic risk factor in this population. © 2022 by the authors. Licensee MDPI, Basel, Switzerland.
